Cantor Fitzgerald adjusted its outlook on Informatica (NYSE:INFA) shares by lowering the price target to $18.00 from the ...

Cantor Fitzgerald reaffirmed its Overweight rating and $118.00 price target for Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE), a biopharmaceutical company specializing in rare diseases. Currently ...

Lutnick, President Donald Trump's nominee to head the Commerce Department, won the bonus for work he did on behalf of Newmark ...

CVS Health (CVS) stock was upgraded by Cantor Fitzgerald to Overweight after the company posted strong Q4 results earlier in ...

Stock analysts at Cantor Fitzgerald issued their FY2025 earnings per share estimates for Axsome Therapeutics in a note issued ...

President Donald Trump’s nominee for U.S. Secretary of Commerce, Howard Lutnick, passed a key procedural vote in the Senate on Thursday, clearing the path for his final confirmation vote.

Cantor Fitzgerald Investment Advisors L.P. decreased its stake in shares of Meta Platforms, Inc. (NASDAQ:META – Free Report) by 1.6% in the fourth quarter, according to its most recent 13F filing with ...

周五，Cantor ...

周五，Cantor Fitzgerald分析师Brett Knoblauch重申对Udemy Inc (NASDAQ: UDMY ...

智通财经获悉，Cantor Fitzgerald将西维斯健康 (CVS.US)评级从“中性”上调至“增持”，并将其12个月目标价从62美元上调至71美元，此前这家管理式医疗巨头公布了好于预期的2024年第四季度财报。